BUZZ-Kenvue falls; Trump eyes 'important' announcement on autism findings Monday

Reuters
2025/09/22
BUZZ-Kenvue falls; Trump eyes 'important' announcement on autism findings Monday

** Shares of Tylenol maker Kenvue KVUE.N fall 3.1% to $17.78 premarket

** U.S. President Donald Trump said on Saturday his administration would make announcement about its autism findings on Monday, declining to offer specifics

** The Wall Street Journal reported earlier this month that Health Secretary Robert F. Kennedy Jr. plans to announce that use of KVUE's popular over-the-counter pain medication Tylenol by pregnant women is potentially linked to autism, contrary to medical guidelines that say it is safe to use

** Kenvue has previously said it continues to believe that taking acetaminophen - the active ingredient in Tylenol - does not cause autism

** Up to last close, stock down 14.1% YTD

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com;))

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10